BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16052546)

  • 1. Artificial neural network prediction of the patterns of deposition of polydisperse aerosols within human lungs.
    Nazir J; Barlow DJ; Jayne Lawrence M; Shrubb I
    J Pharm Sci; 2005 Sep; 94(9):1986-97. PubMed ID: 16052546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial neural network prediction of aerosol deposition in human lungs.
    Nazir J; Barlow DJ; Lawrence MJ; Richardson CJ; Shrubb I
    Pharm Res; 2002 Aug; 19(8):1130-6. PubMed ID: 12240938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an in vitro in vivo correlation for nebulizer delivery using artificial neural networks.
    de Matas M; Shao Q; Silkstone VL; Chrystyn H
    J Pharm Sci; 2007 Dec; 96(12):3293-303. PubMed ID: 17630647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
    Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Count- and mass-based dosimetry of MDI spray droplets with polydisperse and monodisperse size distributions.
    Talaat M; Si X; Liu X; Xi J
    Int J Pharm; 2022 Jul; 623():121920. PubMed ID: 35714818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
    Ali M; Mazumder MK; Martonen TB
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary and Regional Deposition of Nebulized and Dry Powder Aerosols in Ferrets.
    Kuehl PJ; Chand R; McDonald JD; Hava DL; DeHaan WH
    AAPS PharmSciTech; 2019 Jul; 20(6):242. PubMed ID: 31264190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted drug-aerosol delivery in the human respiratory system.
    Kleinstreuer C; Zhang Z; Donohue JF
    Annu Rev Biomed Eng; 2008; 10():195-220. PubMed ID: 18412536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional particle size dependent deposition of inhaled aerosols in rats and mice.
    Kuehl PJ; Anderson TL; Candelaria G; Gershman B; Harlin K; Hesterman JY; Holmes T; Hoppin J; Lackas C; Norenberg JP; Yu H; McDonald JD
    Inhal Toxicol; 2012 Jan; 24(1):27-35. PubMed ID: 22145784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods of calculating lung delivery and deposition of aerosol particles.
    Kim CS
    Respir Care; 2000 Jun; 45(6):695-711. PubMed ID: 10894462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the deposition of inhaled porous drug particles.
    Musante CJ; Schroeter JD; Rosati JA; Crowder TM; Hickey AJ; Martonen TB
    J Pharm Sci; 2002 Jul; 91(7):1590-600. PubMed ID: 12115821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One (sub-)acinus for all: Fate of inhaled aerosols in heterogeneous pulmonary acinar structures.
    Hofemeier P; Koshiyama K; Wada S; Sznitman J
    Eur J Pharm Sci; 2018 Feb; 113():53-63. PubMed ID: 28954217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of inhalation drugs to children for asthma and other respiratory diseases.
    Kwok PC; Chan HK
    Adv Drug Deliv Rev; 2014 Jun; 73():83-8. PubMed ID: 24270011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aerosol therapy].
    Wildhaber JH
    Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicomponent aerosol particle deposition in a realistic cast of the human upper respiratory tract.
    Nordlund M; Belka M; Kuczaj AK; Lizal F; Jedelsky J; Elcner J; Jicha M; Sauser Y; Le Bouhellec S; Cosandey S; Majeed S; Vuillaume G; Peitsch MC; Hoeng J
    Inhal Toxicol; 2017 Feb; 29(3):113-125. PubMed ID: 28470142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an in vitro model to assess deposition of aerosol particles in a representative replica of the rat's respiratory tract.
    Ahmed A; Prime D; Burnell PK; Högger P
    J Aerosol Med Pulm Drug Deliv; 2012 Jun; 25(3):169-78. PubMed ID: 22280010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in predictive understanding of respiratory tract deposition.
    Finlay WH; Martin AR
    J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):189-206. PubMed ID: 18518795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.